Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.19523 | 77 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.19035 | 76 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.89425 | 82 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.18007 | 83 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.41761 | 78 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.13738 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.45378 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.82748 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.39951 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.29641 | 77 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.47922 | 79 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.70113 | 80 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.64233 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.33378 | 78 |